PLATELETBIO

Welcome to the Brand page for “PLATELETBIO”, which is offered here for Platelet bio;research and development related to platelets, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, including, extracellular vesicles or exosomes; research and development in the field of allogeneic cell therapy, platelet variants, drug delivery and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; biotechnology research; research in the field of allogeneic cell therapy, platelet variants and pharmaceutical compositions comprising platelet variants; pharmaceutical research and development; medical research; scientific research; medical and scientific research in the field of allogeneic cell therapy, platelet variants, and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; research and development related to viral vectors and delivery of viral vectors;.

Its status is currently believed to be active. Its class is unavailable. “PLATELETBIO” is believed to be currently owned by “Platelet BioGenesis, Inc.”